Fig. 3
The median PFS of patients with advanced cervical cancer treated with ICIs. B. Diagram for subgroup analysis with PFS greater than 1. This chart focuses on a specific subgroup of patients with PFS greater than 1 and analyses the efficacy of immune checkpoint inhibitor therapy in this subgroup